Login
Get started
Sectors
Healthcare
Pharmaceuticals
Shionogi & Co
4507 —
Shionogi & Co
Share News
¥7,114
0.00
0.00%
Last trade -
00:00
Healthcare
Balanced
Large Cap
High Flyer
Market Cap
¥2tn
Enterprise Value
¥1tn
Revenue
¥427bn
Quality
92
Value
47
Momentum
95
Stock
Rank
™
95
StockReport™
Accounts
Balance sheet
Income statement
Cashflow statement
Dividend summary
News
4507 Dividends
StockReport™
Balance sheet
Income statement
Cashflow
News
4507 Dividends
RCS - Infex Therapeutics - RESP-X successfully completes Phase 1 trial
02/11/2023 08:15
Announcement
RCS - Infex Therapeutics - RESP-X dose escalation approved
18/08/2023 08:15
Announcement
Last trade - 00:00